TScan Therapeutics, Inc. (TCRX) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $0.33 (+1.46%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| May 16, 2024 | Justin Zelin | BTIG | $12.00 | +3548.5% |
Top Analysts Covering TCRX
TCRX vs Sector & Market
| Metric | TCRX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.50 | 2.25 | 2.42 |
| Analyst Count | 6 | 8 | 18 |
| Target Upside | +221.4% | +16187.0% | +19.5% |
| P/E Ratio | -1.26 | 3.79 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3M | $8M | $12M | 4 |
| 2027-12-31 | $8M | $8M | $9M | 4 |
| 2028-12-31 | $15M | $27M | $32M | 4 |
| 2029-12-31 | $28M | $49M | $60M | 3 |
| 2030-12-31 | $48M | $86M | $105M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-1.60 | $-0.93 | $-0.62 | 4 |
| 2027-12-31 | $-1.14 | $-0.87 | $-0.66 | 4 |
| 2028-12-31 | $-1.04 | $-0.81 | $-0.64 | 3 |
| 2029-12-31 | $-0.78 | $-0.60 | $-0.26 | 1 |
| 2030-12-31 | $-0.46 | $-0.36 | $-0.16 | 1 |
Frequently Asked Questions
What is the analyst consensus for TCRX?
The consensus among 6 analysts covering TScan Therapeutics, Inc. (TCRX) is Buy with an average price target of $7.50.
What is the highest price target for TCRX?
The highest price target for TCRX is $12.00, set by Justin Zelin at BTIG on 2024-05-16.
What is the lowest price target for TCRX?
The lowest price target for TCRX is $12.00, set by Justin Zelin at BTIG on 2024-05-16.
How many analysts cover TCRX?
6 analysts have issued ratings for TScan Therapeutics, Inc. in the past 12 months.
Is TCRX a buy or sell right now?
Based on 6 analyst ratings, TCRX has a consensus rating of Buy (2.50/5) with a +221.4% upside to the consensus target of $7.50.
What are the earnings estimates for TCRX?
Analysts estimate TCRX will report EPS of $-0.93 for the period ending 2026-12-31, with revenue estimated at $8M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.